Updates on the DePuy ASR Acetabular Hip Replacement Litigation and Medical Research
This particular device was never specifically approved by the FDA. Now, it is being called "one of the biggest disasters in orthopaedic history." Click here to read more about the process and politics involved which lead to widespread use of this device even in the absence of FDA approval. Many doctors are concerned that those elevated metallic levels can or will produce cardiac and/or neurologic symptoms. Click here to read more.
Rather, it was used "off label" by surgeons in the U.S. In a recent bulletin, the FDA described some of the symptoms to look for to indicate a need for revision surgery, and recommended ongoing vigilance for a variety of symptoms. Click here to view the FDA bulletin. Curiously, the FDA did not advocate checking metallic levels in the blood in the absence of symptoms. Other medical authorities have documented kidney disease resulting from elevated cobalt levels, and point out that kidney disease and other health problems can exist even in the absence of a report of localized hip pain which might more obviously indicate a failure in the device. Click here to read more.
A prudent patient would be advised to consider the medical literature currently available and to discuss with his or her own doctor the need for blood or serum testing, as well as a plan for monitoring into the future as the effects of this unfortunate (but avoidable) disaster gain clarity. From a legal standpoint, the multidistrict litigation in the Northern District of Ohio is continuing. Victims should obtain qualified legal counsel and should generally be wary of settling these cases before more information regarding the adverse health effects.